Molecular genetics of human epilepsies

Expert Reviews in Molecular Medicine

Volumn 1, Issue 19, 1999, Pages 1-22

  Bate, Louise ^a   Gardiner, Mark ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

epilepsies; epilepsy; genetics; ion channel; ion channels; molecular genetics; neurogenetics; neurology

Indexed keywords

EID: 85012434763     PISSN: 14623994     EISSN: 14623994     Source Type: Journal    
DOI: 10.1017/S1462399499001349     Document Type: Article

References (121)

1. Fisher, R.S. (1995) Cellular mechanisms of the epilepsies. In Epilepsy. (2nd edn) (Hopkins, A., Shorvon, S.D. and Cascino, G., eds), pp. 35–58, Chapman & Hall Medical, London, UK
2. Annegers, J.F., Rocca, W.A. and Hauser, W.A. (1996) Causes of epilepsy: contributions of the Rochester epidemiology project. Mayo Clin Proc 71, 570–575, PubMed ID:96232268
3. Phillips, H.A. et al. (1995) Localization of a gene for autosomal dominant nocturnal frontal lobe epilepsy to chromosome 20q 13.2. Nat Genet 10, 117–118, PubMed ID:95375775
4. Steinlein, O.K. et al. (1995) A missense mutation in the neuronal nicotinic acetylcholine receptor alpha 4 subunit is associated with autosomal dominant nocturnal frontal lobe epilepsy. Nat Genet 11, 201–203, PubMed ID:96024658
5. Steinlein, O.K. et al. (1997) An insertion mutation of the CHRNA4 gene in a family with autosomal dominant nocturnal frontal lobe epilepsy. Hum Mol Genet 6, 943–947, PubMed ID:97318806
6. Anand, R. and Lindstrom, J. (1992) Chromosomal localization of seven neuronal nicotinic acetylcholine receptor subunit genes in humans. Genomics 13, 962–967, PubMed ID:92372065
7. Chini, B. et al. (1994) Molecular cloning and chromosomal localization of the human alpha 7-nicotinic receptor subunit gene (CHRNA7). Genomics 19, 379–381, PubMed ID:94245214
8. Wevers, A. et al. (1994) Cellular distribution of nicotinic acetylcholine receptor subunit mRNAs in the human cerebral cortex as revealed by non-isotopic in situ hybridization. Brain Res Mol Brain Res 25, 122–128, PubMed ID:95075232
9. Weiland, S. et al. (1996) An amino acid exchange in the second transmembrane segment of a neuronal nicotinic receptor causes partial epilepsy by altering its desensitization kinetics. FEBS Lett 398, 91–96, PubMed ID:97102719
10. Kuryatov, A. et al. (1997) Mutation causing autosomal dominant nocturnal frontal lobe epilepsy alters Ca2+ permeability, conductance, and gating of human alpha4beta2 nicotinic acetylcholine receptors. J Neurosci 17, 9035–9047, PubMed ID:98033343
11. Phillips, H.A. et al. (1998) Autosomal dominant nocturnal frontal-lobe epilepsy: genetic heterogeneity and evidence for a second locus at 15q24. Am J Hum Genet 63, 1108–1116, PubMed ID:98431796
12. Ronen, G.M. et al. (1993) Seizure characteristics in chromosome 20 benign familial neonatal convulsions. Neurology 43, 1355–1360, PubMed ID:93317193
13. Leppert, M. et al. (1989) Benign familial neonatal convulsions linked to genetic markers on chromosome 20. Nature 337, 647–648, PubMed ID:89143720
14. Lewis, T.B. et al. (1993) Genetic heterogeneity in benign familial neonatal convulsions: identification of a new locus on chromosome 8q. Am J Hum Genet 53, 670–675, PubMed ID:93356161
15. Biervert, C. et al. (1998) A potassium channel mutation in neonatal human epilepsy. Science 279, 403–406, PubMed ID:98092527
16. Singh, N.A. et al. (1998) A novel potassium channel gene, KCNQ2, is mutated in an inherited epilepsy of newborns. Nat Genet 18, 25–29, PubMed ID:98085864
17. Tinel, N. et al. (1998) The KCNQ2 potassium channel: splice variants, functional and developmental expression. Brain localization and comparison with KCNQ3. FEBS Lett 438, 171–176, PubMed ID:99043242
18. Wang, Q. et al. (1996) Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmias. Nat Genet 12, 17–23, PubMed ID:96122034
19. Neyroud, N. et al. (1997) A novel mutation in the potassium channel gene KVLQT1 causes the Jervell and Lange-Nielsen cardioauditory syndrome. Nat Genet 15, 186–189, PubMed ID:97172978
20. Lopez, G.A., Jan, Y.N. and Jan, L.Y. (1994) Evidence that the S6 segment of the Shaker voltage-gated K+ channel comprises part of the pore. Nature 367, 179–182, PubMed ID:94159075
21. Kukuljan, M., Labarca, P. and Latorre, R. (1995) Molecular determinants of ion conduction and inactivation in K+ channels. Am J Physiol 268, C535–556, PubMed ID:95208709
22. Charlier, C. et al. (1998) A pore mutation in a novel KQT-like potassium channel gene in an idiopathic epilepsy family. Nat Genet 18, 53–55, PubMed ID:98085869
23. Schroeder, B.C. et al. (1998) Moderate loss of function of cyclic-AMP-modulated KCNQ2/ KCNQ3 K+ channels causes epilepsy. Nature 396, 687–690, PubMed ID:99087323
24. Molina, A., Ortega-Saenz, P. and Lopez-Barneo, J. (1998) Pore mutations alter closing and opening kinetics in Shaker K+ channels. J Physiol (Lond) 509, 327–337, PubMed ID:98245030
25. Dreyer, I. et al. (1998) Single mutations strongly alter the K+-selective pore of the K(in) channel KAT1. FEBS Lett 430, 370–376, PubMed ID:98351859
26. Guo, L. and Kubo, Y. (1998) Comparison of the open-close kinetics of the cloned inward rectifier K+ channel IRK1 and its point mutant (Q140E) in the pore region. Receptors Channels 5, 273–289, PubMed ID:98330949
27. Barhanin, J. et al. (1996) K(V)LQT1 and lsK (minK) proteins associate to form the I(Ks) cardiac potassium current. Nature 384, 78–80, PubMed ID:97055937
28. Sanguinetti, M.C. et al. (1996) Coassembly of K(V)LQT1 and minK (IsK) proteins to form cardiac I(Ks) potassium channel. Nature 384, 80–83, PubMed ID:97055938
29. Wollnik, B. et al. (1997) Pathophysiological mechanisms of dominant and recessive KVLQT1 K+ channel mutations found in inherited cardiac arrhythmias. Hum Mol Genet 6, 1943–1949, PubMed ID:98027069
30. Lopes-Cendes, I., Lopes-Cendes, I. and Lopes-Cendes, I. (1996) Mapping a locus for idiopathic epilepsy in a large multiplex family. Epilepsia 37(S5), 127
31. Wallace, R.H. et al. (1998) Febrile seizures and generalized epilepsy associated with a mutation in the Na+-channel beta1 subunit gene SCN1B. Nat Genet 19, 366–370, PubMed ID:98361163
32. Makita, N. et al. (1994) Genomic organization and chromosomal assignment of the human voltage- gated Na+ channel beta 1 subunit gene (SCN1B). Genomics 23, 628–634, PubMed ID:95154833
33. Mohrenweiser, H.W. et al. (1998) Regions of sex-specific hypo- and hyper-recombination identified through integration of 180 genetic markers into the metric physical map of human chromosome 19. Genomics 47, 153–162, PubMed ID:98140114
34. Isom, L.L. et al. (1992) Primary structure and functional expression of the beta 1 subunit of the rat brain sodium channel. Science 256, 839–842, PubMed ID:92271207
35. Makita, N., Bennett, P.B., Jr. and George, A.L., Jr. (1994) Voltage-gated Na+ channel beta 1 subunit mRNA expressed in adult human skeletal muscle, heart, and brain is encoded by a single gene. J Biol Chem 269, 7571–7578, PubMed ID:94171787
36. Macdonald, R.L. and Kelly, K.M. (1994) Mechanisms of action of currently prescribed and newly developed antiepileptic drugs. Epilepsia 35, S41–50, PubMed ID:94229033
37. Bulman, D.E. (1997) Phenotype variation and newcomers in ion channel disorders. Hum Mol Genet 6, 1679–1685, PubMed ID:97444127
38. Makita, N., Bennett, P.B. and George, A.L., Jr. (1996) Molecular determinants of beta 1 subunit-induced gating modulation in voltage-dependent Na+ channels. J Neurosci 16, 7117–7127, PubMed ID:97083699
39. McCormick, K.A. et al. (1998) Molecular determinants of Na+ channel function in the extracellular domain of the beta1 subunit. J Biol Chem 273, 3954–3962, PubMed ID:98129801
40. Janz, D., Durner, M. and Beck-Mannagetta, G. (1989) Family studies on the genetics of juvenile myoclonic epilepsy (epilepsy with petit mal). In Genetics of the Epilepsies (Beck-Mannagetta, G. et al., eds), pp. 43–52, Springer-Verlag, Berlin, Germany
41. Greenberg, D.A. et al. (1988) Juvenile myoclonic epilepsy (JME) may be linked to the BF and HLA loci on human chromosome 6. Am J Med Genet 31, 185–192, PubMed ID:89132618
42. Durner, M. et al. (1991) Localization of idiopathic generalized epilepsy on chromosome 6p in families of juvenile myoclonic epilepsy patients. Neurology 41, 1651–1655, PubMed ID:92018869
43. Weissbecker, K.A. et al. (1991) Confirmation of linkage between juvenile myoclonic epilepsy locus and the HLA region of chromosome 6. Am J Med Genet 38, 32–36, PubMed ID:91189241
44. Liu, A.W. et al. (1995) Juvenile myoclonic epilepsy locus in chromosome 6p21.2-p11: linkage to convulsions and electroencephalography trait. Am J Hum Genet 57, 368–381, PubMed ID:95397820
45. Whitehouse, W.P. et al. (1993) Linkage analysis of idiopathic generalized epilepsy (IGE) and marker loci on chromosome 6p in families of patients with juvenile myoclonic epilepsy: no evidence for an epilepsy locus in the HLA region. Am J Hum Genet 53, 652–662, PubMed ID:93356159
46. Elmslie, F.V. et al. (1996) Linkage analysis of juvenile myoclonic epilepsy and microsatellite loci spanning 61 cM of human chromosome 6p in 19 nuclear pedigrees provides no evidence for a susceptibility locus in this region. Am J Hum Genet 59, 653–663, PubMed ID:96354560
47. Elmslie, F.V. et al. (1997) Genetic mapping of a major susceptibility locus for juvenile myoclonic epilepsy on chromosome 15q. Hum Mol Genet 6, 1329–1334, PubMed ID:97402216
48. Breese, C.R. et al. (1997) Comparison of the regional expression of nicotinic acetylcholine receptor alpha7 mRNA and [125I]-alpha-bungarotoxin binding in human postmortem brain. J Comp Neurol 387, 385–398, PubMed ID:97474398
49. Neubauer, B.A. et al. (1998) Centrotemporal spikes in families with rolandic epilepsy: linkage to chromosome 15q14. Neurology 51, 1608–1612, PubMed ID:99071152
50. Dobyns, W.B. and Truwit, C.L. (1995) Lissencephaly and other malformations of cortical development: 1995 update. Neuropediatrics 26, 132–147, PubMed ID:96078491
51. Hattori, M. et al. (1994) Miller-Dieker lissencephaly gene encodes a subunit of brain platelet- activating factor acetylhydrolase [published erratum appears in Nature 1994 Aug 4; 370(6488): 391]. Nature 370, 216–218, PubMed ID:94301405
52. Lo Nigro, C. et al. (1997) Point mutations and an intragenic deletion in LIS1, the lissencephaly causative gene in isolated lissencephaly sequence and Miller-Dieker syndrome. Hum Mol Genet 6, 157–164, PubMed ID:97217774
53. Albrecht, U. et al. (1996) Platelet-activating factor acetylhydrolase expression and activity suggest a link between neuronal migration and platelet-activating factor. Dev Biol 180, 579–593, PubMed ID:97115706
54. Reiner, O. and Sapir, T. (1998) Abnormal cortical development; towards elucidation of the LIS1 gene product function (review). Int J Mol Med 1, 849–853, PubMed ID:99074498
55. Dobyns, W.B. et al. (1996) X-linked malformations of neuronal migration. Neurology 47, 331–339, PubMed ID:96335985
56. des Portes, V. et al. (1998) A novel CNS gene required for neuronal migration and involved in X- linked subcortical laminar heterotopia and lissencephaly syndrome. Cell 92, 51–61, PubMed ID:98149343
57. Gleeson, J.G. et al. (1998) Doublecortin, a brain-specific gene mutated in human X-linked lissencephaly and double cortex syndrome, encodes a putative signaling protein. Cell 92, 63–72, PubMed ID:98149344
58. Sossey-Alaoui, K. et al. (1998) Human doublecortin (DCX) and the homologous gene in mouse encode a putative Ca2+-dependent signaling protein which is mutated in human X-linked neuronal migration defects. Hum Mol Genet 7, 1327–1332, PubMed ID:98334553
59. Gleeson, J.G. et al. (1999) Doublecortin is a microtubule-associated protein and is expressed widely by migrating neurons. Neuron 23, 257–271, PubMed ID:99325520
60. Francis, F. et al. (1999) Doublecortin is a developmentally regulated, microtubule-associated protein expressed in migrating and differentiating neurons. Neuron 23, 247–256, PubMed ID:99325519
61. Huttenlocher, P.R., Taravath, S. and Mojtahedi, S. (1994) Periventricular heterotopia and epilepsy. Neurology 44, 51–55, PubMed ID:94119406
62. Eksioglu, Y.Z. et al. (1996) Periventricular heterotopia: an X-linked dominant epilepsy locus causing aberrant cerebral cortical development. Neuron 16, 77–87, PubMed ID:96158924
63. Fox, J.W. et al. (1998) Mutations in filamin 1 prevent migration of cerebral cortical neurons in human periventricular heterotopia. Neuron 21, 1315–1325, PubMed ID:99098194
64. Lehesjoki, A.E. et al. (1991) Localization of a gene for progressive myoclonus epilepsy to chromosome 21q22. Proc Natl Acad Sci U S A 88, 3696–3699, PubMed ID:91219438
65. Pennacchio, L.A. et al. (1996) Mutations in the gene encoding cystatin B in progressive myoclonus epilepsy (EPM1). Science 271, 1731–1734, PubMed ID:96179676
66. Lalioti, M.D. et al. (1997) Dodecamer repeat expansion in cystatin B gene in progressive myoclonus epilepsy. Nature 386, 847–851, PubMed ID:97271900
67. Virtaneva, K. et al. (1997) Unstable minisatellite expansion causing recessively inherited myoclonus epilepsy, EPM1. Nat Genet 15, 393–396, PubMed ID:97245718
68. Pennacchio, L.A. et al. (1998) Progressive ataxia, myoclonic epilepsy and cerebellar apoptosis in cystatin B-deficient mice. Nat Genet 20, 251–258, PubMed ID:99021380
69. Serratosa, J.M. et al. (1995) The gene for progressive myoclonus epilepsy of the Lafora type maps to chromosome 6q. Hum Mol Genet 4, 1657–1663, PubMed ID:96081235
70. Minassian, B.A. et al. (1998) Mutations in a gene encoding a novel protein tyrosine phosphatase cause progressive myoclonus epilepsy. Nat Genet 20, 171–174, PubMed ID:98442653
71. Serratosa, J.M. et al. (1999) A novel protein tyrosine phosphatase gene is mutated in progressive myoclonus epilepsy of the Lafora type (EPM2). Hum Mol Genet 8, 345–352, PubMed ID:99135915
72. Wallace, D.C. et al. (1988) Familial mitochondrial encephalomyopathy (MERRF): genetic, pathophysiological, and biochemical characterization of a mitochondrial DNA disease. Cell 55, 601–610, PubMed ID:89028671
73. Shoffner, J.M. et al. (1990) Myoclonic epilepsy and ragged-red fiber disease (MERRF) is associated with a mitochondrial DNA tRNA(Lys) mutation. Cell 61, 931–937, PubMed ID:90275613
74. Silvestri, G. et al. (1992) A new mtDNA mutation in the tRNA(Lys) gene associated with myoclonic epilepsy and ragged-red fibers (MERRF). Am J Hum Genet 51, 1213–1217, PubMed ID:93098236
75. Zeviani, M. et al. (1993) A MERRF/MELAS overlap syndrome associated with a new point mutation in the mitochondrial DNA tRNA(Lys) gene [published erratum appears in Eur J Hum Genet 1993; 1(2): 124]. Eur J Hum Genet 1, 80–87, PubMed ID:94348900
76. Zeviani, M., Tiranti, V. and Piantadosi, C. (1998) Mitochondrial disorders. Medicine (Baltimore) 77, 59–72, PubMed ID:98127012
77. Goebel, H.H. and Sharp, J.D. (1998) The neuronal ceroid-lipofuscinoses. Recent advances. Brain Pathol 8, 151–162, PubMed ID:98117377
78. Mole, S.E. (1998) Batten Disease: Four genes and still counting. Neurobiol Dis 5(5), 287–303
79. Elmslie, F.V. and Gardiner, R.M. (1997) The Epilepsies. In Emery and Rimoin's Principles and Practice of Medical Genetics. (3rd edn) (Rimoin, D.L. et al., eds), pp. 2177–2196, Churchill Livingstone, UK
80. Fletcher, C.F. et al. (1996) Absence epilepsy in tottering mutant mice is associated with calcium channel defects. Cell 87, 607–617, PubMed ID:97083572
81. Burgess, D.L. et al. (1997) Mutation of the Ca2+ channel beta subunit gene Cchb4 is associated with ataxia and seizures in the lethargic (lh) mouse. Cell 88, 385–392, PubMed ID:97191307
82. Letts, V.A. et al. (1998) The mouse stargazer gene encodes a neuronal Ca2+-channel gamma subunit. Nat Genet 19, 340–347, PubMed ID:98361159
83. Germano, I.M. et al. (1998) Evidence of enhanced kindling and hippocampal neuronal injury in immature rats with neuronal migration disorders. Epilepsia 39, 1253–1260, PubMed ID:99075402
84. Cavazos, J.E. and Sutula, T.P. (1990) Progressive neuronal loss induced by kindling: a possible mechanism for mossy fiber synaptic reorganization and hippocampal sclerosis [published erratum appears in Brain Res 1991 Feb 8; 541(1): 179]. Brain Res 527, 1–6, PubMed ID:91129575
85. Bengzon, J. et al. (1997) Apoptosis and proliferation of dentate gyrus neurons after single and intermittent limbic seizures. Proc Natl Acad Sci U S A 94, 10432–10437, PubMed ID:97439882
86. Zhang, L.X. et al. (1998) Apoptosis of hippocampal neurons after amygdala kindled seizures. Brain Res Mol Brain Res 55, 198–208, PubMed ID:98250800
87. Fong, G.C. et al. (1998) Childhood absence epilepsy with tonic-clonic seizures and electroencephalogram 3–4-Hz spike and multispike-slow wave complexes: linkage to chromosome 8q24. Am J Hum Genet 63, 1117–1129, PubMed ID:98431797
88. Ottman, R. et al. (1995) Localization of a gene for partial epilepsy to chromosome 10q. Nat Genet 10, 56–60, PubMed ID:95375785
89. Guipponi, M. et al. (1997) Linkage mapping of benign familial infantile convulsions (BFIC) to chromosome 19q. Hum Mol Genet 6, 473–477, PubMed ID:97227294
90. Jarvela, I. et al. (1991) Infantile form of neuronal ceroid lipofuscinosis (CLN1) maps to the short arm of chromosome 1. Genomics 9, 170–173, PubMed ID:91169502
91. Vesa, J. et al. (1995) Mutations in the palmitoyl protein thioesterase gene causing infantile neuronal ceroid lipofuscinosis. Nature 376, 584–587, PubMed ID:95364950
92. Sharp, J.D. et al. (1997) Loci for classical and a variant late infantile neuronal ceroid lipofuscinosis map to chromosomes 11p15 and 15q21–23. Hum Mol Genet 6, 591–595, PubMed ID:97252395
93. Sleat, D.E. et al. (1997) Association of mutations in a lysosomal protein with classical late- infantile neuronal ceroid lipofuscinosis. Science 277, 1802–1805, PubMed ID:97442529
94. Liu, C.G. et al. (1998) Structural organization and sequence of CLN2, the defective gene in classical late infantile neuronal ceroid lipofuscinosis. Genomics 50, 206–212, PubMed ID:98317534
95. Savukoski, M. et al. (1994) Defined chromosomal assignment of CLN5 demonstrates that at least four genetic loci are involved in the pathogenesis of human ceroid lipofuscinoses. Am J Hum Genet 55, 695–701, PubMed ID:95029369
96. Savukoski, M. et al. (1998) CLN5, a novel gene encoding a putative transmembrane protein mutated in Finnish variant late infantile neuronal ceroid lipofuscinosis. Nat Genet 19, 286–288, PubMed ID:98324783
97. Wheeler, R.B. et al. (1999) A new locus for variant late infantile neuronal ceroid lipofuscinosis-CLN7. Mol Genet Metab 66, 337–338, PubMed ID:99208863
98. Das, A.K. et al. (1998) Molecular genetics of palmitoyl-protein thioesterase deficiency in the U.S. J Clin Invest 102, 361–370, PubMed ID:98330462
99. The International Batten Disease Consortium (1995) Isolation of a novel gene underlying Batten disease, CLN3. Cell 82, 949–957, PubMed ID:96016090
100. Mitchison, H.M. et al. (1995) Batten disease gene, CLN3: linkage disequilibrium mapping in the Finnish population, and analysis of European haplotypes. Am J Hum Genet 56, 654–662, PubMed ID:95193793
101. Mitchison, H.M. et al. (1997) Structure of the CLN3 gene and predicted structure, location and function of CLN3 protein. Neuropediatrics 28, 12–14, PubMed ID:97295721
102. O'Rawe, A. et al. (1997) Genetic linkage analysis of a variant of juvenile onset neuronal ceroid lipofuscinosis with granular osmiophilic deposits. Neuropediatrics 28, 21–22, PubMed ID:97295724
103. Mitchison, H.M. et al. (1998) Mutations in the palmitoyl-protein thioesterase gene (PPT; CLN1) causing juvenile neuronal ceroid lipofuscinosis with granular osmiophilic deposits [published erratum appears in Hum Mol Genet 1998 Apr; 7(4): 765]. Hum Mol Genet 7, 291–297, PubMed ID:98087582
104. Tahvanainen, E. et al. (1994) The gene for a recessively inherited human childhood progressive epilepsy with mental retardation maps to the distal short arm of chromosome 8. Proc Natl Acad Sci U S A 91, 7267–7270, PubMed ID:94316676
105. Berkovic, S.F. et al. (1988) Kufs' disease: a critical reappraisal. Brain 111, 27–62, PubMed ID:88209882
106. The European Chromosome 16 Tuberous Sclerosis Consortium (1993) Identification and characterization of the tuberous sclerosis gene on chromosome 16. Cell 75, 1305–1315, PubMed ID:94094325
107. Povey, S. et al. (1994) Two loci for tuberous sclerosis: one on 9q34 and one on 16p13. Ann Hum Genet 58, 107–127, PubMed ID:95069872
108. van Slegtenhorst, M. et al. (1997) Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34. Science 277, 805–808, PubMed ID:97390505
109. de Vries, B.B. et al. (1998) The fragile X syndrome. J Med Genet 35, 579–589, PubMed ID:98341843
110. Cassidy, S.B. and Schwartz, S. (1998) Prader-Willi and Angelman syndromes. Disorders of genomic imprinting. Medicine (Baltimore) 77, 140–151, PubMed ID:98217450
111. Minassian, B.A. et al. (1998) Angelman syndrome: correlations between epilepsy phenotypes and genotypes. Ann Neurol 43, 485–493, PubMed ID:98206406
112. Clarke, A. (1996) Rett syndrome. J Med Genet 33, 693–699, PubMed ID:97016538
113. Gutmann, D.H. and Collins, F.S. (1993) The neurofibromatosis type 1 gene and its protein product, neurofibromin. Neuron 10, 335–343, PubMed ID:93213493
114. Korf, B.R. (1997) Neurocutaneous syndromes: neurofibromatosis 1, neurofibromatosis 2, and tuberous sclerosis. Curr Opin Neurol 10, 131–136, PubMed ID:97292482
115. The Huntington's Disease Collaborative Research Group (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 72, 971–983, PubMed ID:93208892
116. Walling, H.W., Baldassare, J.J. and Westfall, T.C. (1998) Molecular aspects of Huntington's disease. J Neurosci Res 54, 301–308, PubMed ID:99034444
117. Bate, L., Williamson, M. and Gardiner, M. The major susceptibility locus for myoclonic epilepsy on chromosome 15q. In Juvenile Myoclonic Epilepsy (Schmitz, B.and Sander, S., eds), Wrightson Biomedical Publications, Petersfield, UK (in press)
118. Bate, L. and Gardiner, M. (1999) Genetics of idiopathic epilepsy. In Techniques in the Behavioural and Neural Sciences. (Vol. 13) (Crusio, W.E. and Gerlai, R.T., eds), pp. 820–840, Elsevier Science, UK
119. Bate, L. and Gardiner, M. (1999) Genetics of inherited epilepsies. Epileptic Disorders 1, 7–19
120. Hirose, S. et al. (1999) A novel mutation of CHRNA4 responsible for autosomal dominant nocturnal frontal lobe epilepsy. Neurology 53(8) 1749–1753, PubMed ID:20025147
121. Moulard, B. et al. (1999) Identification of a new locus for generalized epilepsy with febrile seizures plus (GEFS+) on chromosome 2q24-q33. Am J Hum Genet 65(5) 1396–1400, PubMed ID:99452601